These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 200629)

  • 1. Use of a mathematical model for neurovirulence assay of attenuated poliovirus.
    Arya SC
    J Biol Stand; 1977; 5(4):283-7. PubMed ID: 200629
    [No Abstract]   [Full Text] [Related]  

  • 2. The behaviour of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
    Arya SC
    J Biol Stand; 1977; 5(4):275-81. PubMed ID: 200628
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurovirulence testing of oral poliovaccine in the rhesus monkey.
    Arya SC
    Indian J Pathol Microbiol; 1976 Jul; 19(3):185-94. PubMed ID: 186408
    [No Abstract]   [Full Text] [Related]  

  • 4. Monkey neurovirulence of live, attenuated (Sabin) type I and type II poliovirus vaccines.
    Marsden SA; Boulger LR; Magrath DI; Reeve P; Schild GC; Taffs LF
    J Biol Stand; 1980; 8(4):303-9. PubMed ID: 7009616
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains].
    Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291066
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types].
    Unterharnscheidt F; Bonin O; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(1):1-12. PubMed ID: 4290953
    [No Abstract]   [Full Text] [Related]  

  • 9. TgPVR21 mice for testing type-3 oral poliovirus vaccines: role of clinical observation and histological examination.
    Dragunsky E; Chernokhvostova Y; Taffs R; Chumakov K; Gardner D; Asher D; Nomura T; Hioki K; Levenbook I
    Vaccine; 1997 Dec; 15(17-18):1863-6. PubMed ID: 9413095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291332
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative monkey neurovirulence of Sabin type III poliovirus vaccines.
    Boulger LR; Marsden SA; Magrath DI; Taffs LF; Schild GC
    J Biol Stand; 1979 Apr; 7(2):97-111. PubMed ID: 225329
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphometric method for evaluating the neurovirulence of live poliomyelitis vaccine.
    Tyufanov AV; Stefanov SB
    Bull World Health Organ; 1979; 57(5):815-7. PubMed ID: 232013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of safety and potency tests of vaccines against poliomyelitis.
    Elisberg BL
    Rev Infect Dis; 1984; 6 Suppl 2():S519-22. PubMed ID: 6330850
    [No Abstract]   [Full Text] [Related]  

  • 14. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.
    Rezapkin GV; Douthitt M; Dragunsky E; Chumakov KM
    Virus Res; 1999 Dec; 65(2):111-9. PubMed ID: 10581384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated oral poliovirus vaccine.
    Melnick JL
    Rev Infect Dis; 1984; 6 Suppl 2():S323-7. PubMed ID: 6330836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral poliomyelitis vaccination: why should transmission of vaccine viruses to unvaccinated infants be avoided if possible?].
    Wiersbitzky S
    Kinderarztl Prax; 1993 May; 61(3):120-1. PubMed ID: 8392122
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells.
    Guo R; Chen SF; Luo GX; Luo QS; Xu QF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
    Chin Med J (Engl); 1980 Sep; 93(9):591-8. PubMed ID: 6253237
    [No Abstract]   [Full Text] [Related]  

  • 19. Poliomyelitis vaccines: killed or live?
    Br Med J; 1978 Sep; 2(6141):845-6. PubMed ID: 709087
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine.
    Chumakov KM; Powers LB; Noonan KE; Roninson IB; Levenbook IS
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):199-203. PubMed ID: 1846038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.